Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/10/2013US20130267553 Liquid pharmaceutical formulations of palonosetron
10/10/2013US20130267552 Pharmaceutical compositions for combination therapy
10/10/2013US20130267550 Compounds and Methods for Treating Aberrant Adrenocartical Cell Disorders
10/10/2013US20130267549 Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis
10/10/2013US20130267548 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
10/10/2013US20130267544 Use of LP-PLA2 Inhibitors in the Treatment and Prevention of Eye Diseases
10/10/2013US20130267538 Treatment of mitochondrial diseases
10/10/2013US20130267537 Heterocyclic sulfonamides
10/10/2013US20130267535 Treatment of Chronic Inflammation with a 1,2,4-Triazolo [1,5a] Pyridine Derivative
10/10/2013US20130267533 5ht1a agonists for treatment of high cholesterol
10/10/2013US20130267528 Trans-epithelial osmotic collyrium for the treatment of keratoconus
10/10/2013US20130267522 Methods for treating cancer
10/10/2013US20130267515 Combination comprising an atp analog and an adenosine receptor antagonist or a nucleobase/nucleoside analog for the treatment of cancer
10/10/2013US20130267513 Pyrazolopyridines as inhibitors of the kinase lrrk2
10/10/2013US20130267509 Thiazole derivatives
10/10/2013US20130267506 Therapeutic compositions for diabetic symmetrical polyneuropathy
10/10/2013US20130267502 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
10/10/2013US20130267500 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
10/10/2013US20130267499 NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
10/10/2013US20130267498 Compounds useful as protein kinase inhibitors
10/10/2013US20130267497 Kinase inhibitors
10/10/2013US20130267492 Aryl sulfonamides
10/10/2013US20130267490 Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
10/10/2013US20130267489 Fulvestrant formulations
10/10/2013US20130267488 Pharmaceutical formulation having neuroprotective activity
10/10/2013US20130267487 Composition for prevention of nausea or vomiting
10/10/2013US20130267485 Pharmaceutical Combination of Resveratrol and Progestin to Treat and/or Prevent Myoma and/or Endometriosis
10/10/2013US20130267484 Treatment of rheumatoid arthritis with masitinib
10/10/2013US20130267480 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
10/10/2013US20130267477 Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia
10/10/2013US20130267475 Method of Treating Neurological Conditions with Oleandrin
10/10/2013US20130267469 Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
10/10/2013US20130267461 Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events
10/10/2013US20130267456 Therapeutic applications of smad7
10/10/2013US20130266673 Compositions and methods for treatment and management of pain
10/10/2013US20130266668 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
10/10/2013US20130266667 Pharmaceutical combination for the treatment of renal failure in pets
10/10/2013US20130266666 Combination Therapy with an Antitumor Alkaloid
10/10/2013US20130266663 Sox9 inhibitors
10/10/2013US20130266659 Methods of treating bladder cancer
10/10/2013US20130266651 Long acting dual release product containing carbinoxamine and pseudoephedrine
10/10/2013US20130266650 Bupropion hydrobromide and therapeutic applications
10/10/2013US20130266649 Novel pharmaceutical composition
10/10/2013US20130266648 Tableted compositions containing atazanavir
10/10/2013US20130266647 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/10/2013US20130266646 Pharmaceutical formulations comprising ccr3 antagonists
10/10/2013US20130266645 Derivatives of steroid benzylamines, having an antiparasitic antibacterial, antimycotic and/or antiviral action
10/10/2013US20130266643 Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis
10/10/2013US20130266640 Modified nucleoside, nucleotide, and nucleic acid compositions
10/10/2013US20130266639 METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNA
10/10/2013US20130266636 Methods for blocking cell proliferation and treating diseases and conditions responsive to cell growth inhibition
10/10/2013US20130266633 Transdermal Therapeutic System
10/10/2013US20130266632 Drug delivery system based on polyethylene vinylacetate copolymers
10/10/2013US20130266631 Clonidine compounds in a biodegradable matrix
10/10/2013US20130266620 Medical material and method for manufacturing same
10/10/2013US20130266619 Biocompatible Polyacrylate Compositions For Medical Applications
10/10/2013US20130266615 Non-immunogenic delivery vehicle for beta-, gamma-, and delta-tocopherols and methods of using and making same
10/10/2013US20130266591 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies
10/10/2013US20130266590 Dimeric iap inhibitors
10/10/2013US20130266588 Agents, Compositions, And Methods For Treating Pruritis And Related Skin Conditions
10/10/2013US20130266578 Methods of treating an overweight subject
10/10/2013US20130266574 Human antibodies to human angiopoietin-like protein 4
10/10/2013US20130266572 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone- resistant cancers
10/10/2013US20130266571 Three-dimensional structure of complement receptor type 2 and uses thereof
10/10/2013US20130266563 Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof
10/10/2013US20130266557 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10)
10/10/2013US20130266556 Processing biomass
10/10/2013US20130266549 Highly biocompatible dual thermogelling chitosan/glucosamine salt composition
10/10/2013US20130266545 Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
10/10/2013US20130266538 Solid Forms of a Thiophosphoramidate Nucleotide Prodrug
10/10/2013US20130266534 Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol
10/10/2013US20130266508 Thermosensitive hydrogel for coating radioisotope and chemotherapeutic agent to treat cancer and method for preparing the same
10/10/2013US20130263852 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
10/10/2013DE102012103041A1 New isolated antisense-oligonucleotide comprising sequence that is hybridized to messenger RNA-splicing-sequence of mutation-bearing exons of pre-messenger RNA of titin-gene and induces skipping of exons, used to treat heart disease
10/10/2013DE102012102414A1 Composition, used to treat diabetes mellitus, includes antidiabetic drug as active substance, preferably metformin or its salt, where the composition is divided into two compartments, which include drug and three groups of adjuvants
10/10/2013DE102012007239A1 Pharmazeutische Zusammensetzung enthaltend eine mit Sauerstoff angereicherte ungesättigte Fettsäure und ein organisches Lösungsmittel A pharmaceutical composition comprising an oxygen-enriched unsaturated fatty acid and an organic solvent
10/10/2013DE102012007165A1 Saures Dialysekonzentrat Treat dialysis concentrate
10/10/2013DE102012006903A1 Neue aromatische Heterocyclen, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend neue aromatische Heterocyclen New aromatic heterocycles, to processes for their preparation and medicines containing novel aromatic heterocycles
10/10/2013DE102012006884A1 Cyclische Amide als MetAP-2 Inhibitoren Cyclic amides as MetAP-2 inhibitors
10/09/2013EP2647713A1 Modified single-strand polynucleotide
10/09/2013EP2647712A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
10/09/2013EP2647708A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
10/09/2013EP2647649A1 Hyaluronic acid gel, method for producing the hyaluronic acid gel and medical product with the hyaluronic acid gel
10/09/2013EP2647638A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013EP2647637A2 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
10/09/2013EP2647635A1 Pyrrole derivative and process for production thereof
10/09/2013EP2647634A1 Indole-pyrimidine derivatives and their therapeutic uses
10/09/2013EP2647630A1 Biguanide derivative compound
10/09/2013EP2647629A1 Pyrazole compound having therapeutic effect on multiple myeloma
10/09/2013EP2647628A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013EP2647627A1 Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
10/09/2013EP2647622A1 Novel compound, and kinesin spindle protein inhibitor and application thereof
10/09/2013EP2647619A1 Novel compound and medical use thereof
10/09/2013EP2647397A1 Acidic concentrate for dialysis
10/09/2013EP2647386A1 Lissencephaly therapeutic agent
10/09/2013EP2647384A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Va-Ja , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
10/09/2013EP2647382A1 Compositions and methods for treating epithelial and retinal tissue diseases
10/09/2013EP2647381A1 Orally disintegrating tablet
10/09/2013EP2647380A2 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
10/09/2013EP2647379A1 Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 7860